Skip to main navigation

Vivek Ramaswamy

Founder & CEO

Roivant Sciences

OUR STORY
OUR PIPELINE
OUR PEOPLE
ROIVANT DISCOVERY
INVESTOR RELATIONS +
JOIN US

Press Releases

Year

May 19, 2022

Roivant to Present at Upcoming Investor Conferences

May 16, 2022

Aruvant Announces Oral Presentation at American Society of Gene and Cell Therapy (ASGCT)

May 2, 2022

Roivant Appoints Chief Development Officer and Announces Multiple Collaborations in Targeted Protein Degradation

March 25, 2022

Dermavant Showcases New Long-Term Durability and Tolerability Data from Phase 3 PSOARING 3 Trial of Tapinarof Cream for Adults with Plaque Psoriasis at the 2022 AAD Annual Meeting

March 11, 2022

Roivant to Present at Targeted Protein Degradation Conference

February 28, 2022

Genevant Sciences and Arbutus Biopharma File Patent Infringement Lawsuit Against Moderna

February 14, 2022

Roivant Sciences Reports Financial Results for the Quarter Ended December 31, 2021 and Provides Business Update

February 7, 2022

Roivant to Report Financial Results for the Quarter Ended December 31, 2021 on Monday, February 14, 2022

January 25, 2022

Roivant to Present at Upcoming Investor Conferences

January 5, 2022

Roivant Licenses Splicing Modulator and Announces Upcoming Presentation at 40th Annual J.P. Morgan Healthcare Conference

Print Page
Email Alerts
RSS Feeds
IR Contacts

© 2022 Roivant Sciences Ltd.

Careers Privacy Policy

Follow us on LinkedIn